Stephen A. Whelan: How SARS-CoV-2 Infection Reprograms Tryptophan Metabolism
Stephen A. Whelan, Founder at Tamino Bio, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Vessels, Thrombosis and Hemostasis, adding:
“Congratulations to Vipul Chitalia, Saravanan Subramaniam, Marc Napoleon, and the entire team on this publication.
In this collaborative study, the authors investigated how SARS-CoV-2 infection reprograms tryptophan metabolism and contributes to a prothrombotic state through activation of the kynurenine–AHR–tissue factor signaling axis.
Key findings included:
- SARS-CoV-2 infection increased kynurenine pathway metabolites in both mouse models and human patients.
- Elevated kynurenine signaling was associated with activation of procoagulant pathways in endothelial cells.
- Pharmacologic inhibition of IDO-1 or AHR reduced tissue factor induction, highlighting a potentially targetable pathway linking metabolism, inflammation, and thrombosis.
- The study identified the kynurenine–AHR–TF axis as a potential diagnostic and therapeutic target for COVID-19-associated thrombosis.
I was pleased to contribute metabolomics analyses to this work using the metabolomics platform I built and operated at Boston University’s Chemical Instrumentation Center (CIC) between 2018–2021.
Studies like this demonstrate the value of integrating metabolomics, proteomics, and systems biology approaches to better understand disease mechanisms and identify new diagnostic and therapeutic opportunities.”
Title: Tryptophan metabolism reprogramming potentially contributes to the prothrombotic milieu in mice and humans with SARS-CoV-2
Authors: Saravanan Subramaniam, Marc Arthur Napoleon, Saran Lotfollahzadeh, Mohamed Hassan Kamal, Helena Kurniawan, Christina Francis, Murad Elsadawi, David Jasen Wu Wong, Devin Kenney, Florian Douam, Markus Bosmann, Stephen A. Whelan, Howard Cabral, Eric J. Burks, Grace Zhao, Vijaya B. Kolachalama, Katya Ravid, Vipul C. Chitalia
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 19, 2026, 02:55Strengthening Laboratory Capacity for Earlier Sickle Cell Disease Diagnosis Across Africa – ASH
-
Jun 19, 2026, 00:03Veronica Sanchez: Did You Know That Acute Pulmonary Embolism Can Be Sudden and Serious?
-
Jun 18, 2026, 23:52WFH Regional Conference on Advancing Bleeding Disorders Care
-
Jun 18, 2026, 23:30Vikas Dua: Creating a Future Free From Sickle Cell Disease for Children Worldwide
-
Jun 18, 2026, 22:50Satish C Tajne: MHEI 2026 Marks a Milestone in Advancing Hematology Care
-
Jun 18, 2026, 20:32Julia Owens: A Deep Dive Into Stroke Care and Basking Bio’s Innovative Programs
-
Jun 18, 2026, 19:53Astha Thakkar: What Is the Most Important Test for a Bleeding Disorder?
-
Jun 18, 2026, 19:53Shehab Mohamed: Real-World Evidence on Maternal and Neonatal Outcomes in ITP
-
Jun 18, 2026, 19:51Mawadda Chukr: What 10 Randomized Trials Reveal About Novel ITP Therapies